Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
10 hedge funds and large institutions have $11.5M invested in Forward Pharma A/S American Depositary Shares in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
50% more capital invested
Capital invested by funds: $7.68M → $11.5M (+$3.85M)
23% less funds holding
Funds holding: 13 → 10 (-3)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$27.8K |
| 2 |
PCG
Private Capital Group
West Hartford,
Connecticut
|
+$563 |
| 3 |
RCAG
Rehmann Capital Advisory Group
Lansing,
Michigan
|
+$294 |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$219 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$24K |
| 2 |
Renaissance Technologies
New York
|
-$20.4K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$18K |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
-$17K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5.57K |
FWP Hedge Fund Activity: Q1 2019 in Review
10 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q1 2019, worth a combined $11.5M — up 50% from $7.68M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of FWP and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, adding an estimated $27.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $24K sold.
- 10 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q1 2019, down from 13 in Q4 2018.
- Funds reported $11.5M of Forward Pharma A/S American Depositary Shares stock for Q1 2019, up 50% quarter-over-quarter.
- 3 funds opened new Forward Pharma A/S American Depositary Shares positions in Q1 2019 and 5 closed out, a net change of -2 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q1 2019 was Morgan Stanley, an estimated $27.8K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q1 2019 was Citadel Advisors, an estimated $24K sold.
Based on aggregated 13F filings for Q1 2019.